AOR - VeinEase

Hide

To
From
Confirm Email
Subject
Message

Indications
Ingredients
Description
Quantity
Dose
Safety
References

VeinEase

Buy {{ format.languages[$root.language].name }} for {{ format.actual_price | currency }}

Manufacturer:	AOR
Code:	AOR08281
NPN:	80029551

Indications
Ingredients
Description
Quantity
Dose
Safety
Reference

Indications

• Chronic Venous Insufficiency (CVI)
• Varicose veins
• Antioxidant
• Cardiovascular health

Ingredients

Serving Size: 1 Capsule%DV
Diosmin (from Citrus aurantium)450 mg†
Grape Seed extract ( 85% oligomeric proanthocyanadins)75 mg†
Hesperidin (from Citrus aurantium)50 mg†
† Daily Value not established

Description

What Is It?
The VeinEase formula is based on a pharmaceutical treatment in Europe for chronic venous insufficiency (CVI) but is 100% natural. VeinEase provides clinically proven doses and ratios of the flavonoids diosmin and hesperidin, complemented by grape seed extract.

What Does It Do?
Primary Uses: VeinEase promotes healthy veins, especially in the legs. Vein and valve dysfunction in the legs leads to CVI as well as varicose veins. VeinEase helps maintain vascular structure and function, reducing blood pooling and fluid build-up in the legs. This in turn reduces pain, inflammation and skin ulcerations related to dysfunctional veins.
Secondary Uses: These flavonoids also have cardiovascular benefits. Grape seed extract is known to support healthy blood pressure, and ensuring that blood is returning to the heart from the legs is essential for adequate cardiovascular function.

Who Should Take It?
Those with chronic venous insufficiency (CVI), poor circulation, painful veins or varicose veins may find relief from VeinEase. VeinEase is an excellent travel companion that may help reduce blood pooling or swelling of the legs during airplane flights or extended periods of sitting.

Quantity

60 Vegi-Caps

Dose

Take 1 capsule twice daily with/without food, or as directed by a qualified health care practitioner. Use for a minimum of 1 month to see beneficial effects.

Potential side effects/Safety

5209

References

"Show references"

"Hide references"

Bergan JJ, Schmid-SchÖnbein GW, Takase S. Therapeutic approach to chronic venous insufficiency and its complications: place of Daflon 500 mg. Angiology. 2001 Aug;52 Suppl 1:S43-7.

Costantini A, De Bernardi T, Gotti A. Clinical and capillaroscopic evaluation of chronic uncomplicated venous insufficiency with procyanidins extracted from vitis vinifera. Minerva Cardioangiol. 1999 Jan-Feb;47(1-2):39-46.

Jantet G. Chronic venous insufficiency: worldwide results of the RELIEF study. Reflux assEssment and quaLity of lIfe improvEment with micronized Flavonoids. Angiology. 2002 May-Jun;53(3):245-56.

Monograph. Diosmin. Altern Med Rev. 2004 Sep;9(3):308-11.

Nicolaides AN. From symptoms to leg edema: efficacy of Daflon 500 mg. Angiology. 2003 Jul-Aug;54 Suppl 1:S33-44.

Smith PC. Daflon 500 mg and venous leg ulcer: new results from a meta-analysis. Angiology. 2005 Sep-Oct;56 Suppl 1:S33-9.

Disclaimer: This content is subject to change. The information is intended to inform and educate; it does not replace the medical evaluation, advice, diagnosis or treatment by a healthcare professional. www.nhpassist.com © 2014 NDAssist Inc. and/or its affiliates. All rights reserved.